Alpha 1-antichymotrypsin

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
Identifiers
Symbol SERPINA3
Alt. Symbols AACT
Entrez 12
HUGO 16
OMIM 107280
RefSeq NM_001085
UniProt P01011
Other data
Locus Chr. 14 q32.1

WikiDoc Resources for

Alpha 1-antichymotrypsin

Articles

Most recent articles on Alpha 1-antichymotrypsin

Most cited articles on Alpha 1-antichymotrypsin

Review articles on Alpha 1-antichymotrypsin

Articles on Alpha 1-antichymotrypsin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Alpha 1-antichymotrypsin

Images of Alpha 1-antichymotrypsin

Photos of Alpha 1-antichymotrypsin

Podcasts & MP3s on Alpha 1-antichymotrypsin

Videos on Alpha 1-antichymotrypsin

Evidence Based Medicine

Cochrane Collaboration on Alpha 1-antichymotrypsin

Bandolier on Alpha 1-antichymotrypsin

TRIP on Alpha 1-antichymotrypsin

Clinical Trials

Ongoing Trials on Alpha 1-antichymotrypsin at Clinical Trials.gov

Trial results on Alpha 1-antichymotrypsin

Clinical Trials on Alpha 1-antichymotrypsin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Alpha 1-antichymotrypsin

NICE Guidance on Alpha 1-antichymotrypsin

NHS PRODIGY Guidance

FDA on Alpha 1-antichymotrypsin

CDC on Alpha 1-antichymotrypsin

Books

Books on Alpha 1-antichymotrypsin

News

Alpha 1-antichymotrypsin in the news

Be alerted to news on Alpha 1-antichymotrypsin

News trends on Alpha 1-antichymotrypsin

Commentary

Blogs on Alpha 1-antichymotrypsin

Definitions

Definitions of Alpha 1-antichymotrypsin

Patient Resources / Community

Patient resources on Alpha 1-antichymotrypsin

Discussion groups on Alpha 1-antichymotrypsin

Patient Handouts on Alpha 1-antichymotrypsin

Directions to Hospitals Treating Alpha 1-antichymotrypsin

Risk calculators and risk factors for Alpha 1-antichymotrypsin

Healthcare Provider Resources

Symptoms of Alpha 1-antichymotrypsin

Causes & Risk Factors for Alpha 1-antichymotrypsin

Diagnostic studies for Alpha 1-antichymotrypsin

Treatment of Alpha 1-antichymotrypsin

Continuing Medical Education (CME)

CME Programs on Alpha 1-antichymotrypsin

International

Alpha 1-antichymotrypsin en Espanol

Alpha 1-antichymotrypsin en Francais

Businness

Alpha 1-antichymotrypsin in the Marketplace

Patents on Alpha 1-antichymotrypsin

Experimental / Informatics

List of terms related to Alpha 1-antichymotrypsin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Alpha 1-antichymotrypsin is an alpha globulin glycoprotein that is a member of the serine proteinase inhibitor (serpin) family.

It inhibits the activity of certain enzymes called proteinases, such as cathepsin G that is found in neutrophils, and chymases found in mast cells, by cleaving them into a different shape or conformation. This activity protects some tissues, such as the lower respiratory tract, from damage caused by proteolytic enzymes.[1]

Alpha 1-antichymotrypsin is also associated with the pathogenesis of Alzheimer's disease as it enhances the formation of amyloid-fibrils in this disease.[1]

This enzyme is produced in the liver, and is an acute phase protein that is induced during inflammation.

References


External links

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools